Published in J Am Coll Cardiol on November 01, 2016
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention. J Am Coll Cardiol (2015) 1.62
Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: Insights from the ADAPT-DES study. Catheter Cardiovasc Interv (2016) 1.42
Stent placement vs. balloon angioplasty for popliteal artery treatment: two-year results of a prospective, multicenter, randomized trial. J Endovasc Ther (2015) 1.42
Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials. Catheter Cardiovasc Interv (2015) 1.39
Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention). JACC Cardiovasc Interv (2015) 0.88
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. J Am Coll Cardiol (2016) 0.87
Relation of C-reactive protein levels to instability of untreated vulnerable coronary plaques (from the PROSPECT Study). Am J Cardiol (2014) 0.87
Prompt benefit of early immunosuppressive therapy in acute lymphocytic myocarditis with persistent heart failure. Clin Res Cardiol (2016) 0.85
Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy). Am J Cardiol (2015) 0.79
Relationship Between Platelet Reactivity and Culprit Lesion Morphology: An Assessment From the ADAPT-DES Intravascular Ultrasound Substudy. JACC Cardiovasc Imaging (2016) 0.78
TCT-820 Multivessel Intracoronary Infusion of Allogeneic Cardiosphere Derived Cells in Dilated Cardiomyopathy: Long Term Outcomes of the Dilated Cardiomyopathy Intervention with Allogeneic Myocardially-Regenerative Cells (DYNAMIC Trial). J Am Coll Cardiol (2016) 0.75
Predictors and Long-Term Clinical Impact of Acute Stent Malapposition: An Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) Intravascular Ultrasound Substudy. J Am Heart Assoc (2016) 0.75
TCT-313 Incidence and Predictors of Very Late Major Adverse Cardiac Events After Metallic Stents: A Patient-Level Pooled Analysis from Seventeen Randomized Trials. J Am Coll Cardiol (2016) 0.75
TCT-421 In Vivo Serial Assessment of Coronary Vessel Geometry Restoration and Resorption Process Following the Implantation of Second-Generation Drug-Eluting Absorbable Metal Scaffold (DREAMS 2G): Insights from the BIOSOLVE-II First-In-Man Trial. J Am Coll Cardiol (2016) 0.75
TCT-453 Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. J Am Coll Cardiol (2016) 0.75
TCT-201 Incidence and Implications of Presentation With Ventricular Tachycardia or Fibrillation in Patients With STEMI Undergoing Primary PCI: The HORIZONS-AMI Trial. J Am Coll Cardiol (2016) 0.75
TCT-322 The Smoker's Paradox Revisited: A 5-Year Patient-Level Pooled Analysis of 17 Randomized Controlled Trials. J Am Coll Cardiol (2016) 0.75
TCT-55 Risk-Benefit Analysis of Upstream Antithrombotic Therapy in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes Prior to Coronary Angiography. J Am Coll Cardiol (2016) 0.75
TCT-273 Predictors of successful Stingray-assisted antegrade dissection reentry: data from the Progress CTO registry. J Am Coll Cardiol (2016) 0.75
TCT-206 Tailoring the Intensity of Antiplatelet Pharmacotherapy to Ischemic and Bleeding Risk: A Cost Optimizing Simulation From PARIS. J Am Coll Cardiol (2016) 0.75
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy. JACC Cardiovasc Interv (2022) 0.75
Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry. JACC Cardiovasc Interv (2016) 0.75
TCT-15 Use of Antegrade Dissection Re-entry in Coronary Chronic Total Occlusion Percutaneous Coronary Intervention in a Contemporary Multicenter Registry. J Am Coll Cardiol (2016) 0.75
Prevalence and Clinical Impact of Tissue Protrusion After Stent Implantation: An ADAPT-DES Intravascular Ultrasound Substudy. JACC Cardiovasc Interv (2016) 0.75
TCT-61 Long-term Outcomes of Patients with Left Ventricular Dysfunction Undergoing Percutaneous Coronary Intervention for Chronic Total Occlusion. J Am Coll Cardiol (2016) 0.75
Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents. Int J Cardiol (2016) 0.75
TCT-263 Impact of Diabetes on Clinical Outcomes in Patients Undergoing Unprotected Left Main Percutaneous Coronary Intervention with Drug-Eluting Stents. J Am Coll Cardiol (2016) 0.75
TCT-572 Use of Intravascular Imaging During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from a Contemporary Multicenter Registry. J Am Coll Cardiol (2016) 0.75
TCT-2 Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Infarct Size: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials. J Am Coll Cardiol (2016) 0.75
TCT-200 Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes by Culprit Coronary Artery in Patients With STEMI Undergoing Primary PCI: The HORIZONS-AMI Trial. J Am Coll Cardiol (2016) 0.75
The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES Study. JACC Cardiovasc Interv (2016) 0.75
TCT-7 Relationship Between Traditional Risk Factors, Platelet Reactivity, and Thrombotic Events: A Mediation Analysis From ADAPT-DES. J Am Coll Cardiol (2016) 0.75
TCT-308 Impact of Race and Ethnicity on Technical and In-Hospital Outcomes Following Chronic Total Occlusions Percutaneous Coronary Intervention. J Am Coll Cardiol (2016) 0.75
TCT-133 Use of a Micro-axial Percutaneous Left Ventricular Assist Device (pLVAD) for Patients with Cardiogenic Shock. J Am Coll Cardiol (2016) 0.75
TCT-166 Correlates and Prognostic Impact of New-Onset Heart Failure after ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Insights from the INFUSE-AMI Trial. J Am Coll Cardiol (2016) 0.75
Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study). Am J Cardiol (2017) 0.75
TCT-205 Incidence and clinical outcomes associated with DAPT discontinuation in complex PCI patients: From the PARIS registry. J Am Coll Cardiol (2016) 0.75
TCT-448 BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) - 4 Year Clinical Results. J Am Coll Cardiol (2016) 0.75
Does calcium burden impact culprit lesion morphology and clinical results? An ADAPT-DES IVUS substudy. Int J Cardiol (2017) 0.75
TCT-8 Impact of Aspirin Resistance on Outcomes after Coronary Events. J Am Coll Cardiol (2016) 0.75
TCT-222 Clinical Outcomes of Dual Antiplatelet Therapy after Coronary Stenting in Patients with Chronic Kidney Disease: Patient-level Meta-analysis of 4 Randomized Clinical Trials. J Am Coll Cardiol (2016) 0.75
TCT-168 Worse Outcomes in Women Compared to Men After Primary PCI in STEMI Are Not Explained by Left Ventricular Morphology and Cardiac Function: A Collaborative Patient-Level Pooled Analysis from 9 Randomized Trials. J Am Coll Cardiol (2016) 0.75
TCT-674 Sex Specific Outcomes of TAVR with the Sapien 3 Valve: Insights From The PARTNER 2 S3 High-Risk and Intermediate-Risk Cohorts. J Am Coll Cardiol (2016) 0.75
TCT-583 Intravascular Ultrasound Comparison of Intra-plaque Versus Subintimal Tracking in Percutaneous Intervention for Coronary Chronic Total Occlusions. J Am Coll Cardiol (2016) 0.75
TCT-213 Efficacy and Safety of Long- Versus Short-Term Dual Antiplatelet Therapy Following Complex Percutaneous Coronary Intervention with Drug-Eluting Stents: A Collaborative Patient-Level Pooled Analysis of Randomized Controlled Trials. J Am Coll Cardiol (2016) 0.75
TCT-66 Effects of dual antiplatelet therapy cessation among patients with diabetes mellitus after PCI with DES. J Am Coll Cardiol (2016) 0.75
TCT-36 Frailty in Intermediate Risk Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement, Cut Points and Relationship With Outcomes: An Analysis of the Placement of Aortic Transcatheter Valves (PARTNER) 2 Cohort A Randomized Trial. J Am Coll Cardiol (2016) 0.75
TCT-163 Time to Reperfusion and Infarct Size in Patients With STEMI Undergoing Primary PCI: A Collaborative Patient-Level Pooled Analysis of 10 Randomized Trials. J Am Coll Cardiol (2016) 0.75
Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry. Int J Cardiol (2017) 0.75
TCT-30 Safety, Clinical Performance and multi-modality imaging data of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 12-month follow-up-BIOSOLVE-II. J Am Coll Cardiol (2016) 0.75
TCT-546 Imaging and physiology-guided zero contrast percutaneous coronary intervention in advanced chronic kidney disease. J Am Coll Cardiol (2016) 0.75
TCT-63 Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction. J Am Coll Cardiol (2016) 0.75
TCT-237 Outcomes After Successful PCI of Severely Calcified Lesions Using Rotational Atherectomy, Cutting Balloon, or Balloon Angioplasty only Before Second-Generation Drug-Eluting Stent Implantation. J Am Coll Cardiol (2016) 0.75
TCT-301 Outcomes of Percutaneous Coronary Intervention in Chronic Total Occlusions Caused by In-Stent Restenosis: Insights from a U.S. Multicenter Registry. J Am Coll Cardiol (2016) 0.75
Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study. Int J Cardiol (2017) 0.75
Percutaneous coronary intervention of bifurcation lesions and platelet reactivity. Int J Cardiol (2017) 0.75
TCT-725 General Anaesthesia or Conscious Sedation for Transfemoral Aortic Valve Replacement with the SAPIEN 3 Transcatheter Heart Valve in 1681 Patients. J Am Coll Cardiol (2016) 0.75
TCT-278 Application and Outcomes of the Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention: an Update from a Contemporary Multicenter US Registry. J Am Coll Cardiol (2016) 0.75
TCT-198 Worsening Atrioventricular Conduction After Hospital Discharge in Patients With STEMI Undergoing Primary PCI: The HORIZONS-AMI Trial. J Am Coll Cardiol (2016) 0.75
TCT-236 Effects of Orbital Versus Rotational Atherectomy Facilitated PCI on the Coronary Microcirculation. J Am Coll Cardiol (2016) 0.75
TCT-65 Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With and Without Insulin Treatment: A pooled patient level analysis from 17 randomized trials. J Am Coll Cardiol (2016) 0.75
TCT-219 Influence Of Anemia On Physician-Recommended DAPT Discontinuation After Percutaneous Coronary Intervention. J Am Coll Cardiol (2016) 0.75
TCT-211 Incidence and Impact of Dual Antiplatelet Therapy Cessation on Clinical Outcomes in Patients with Renal Dysfunction: Insights from the PARIS Registry. J Am Coll Cardiol (2016) 0.75
Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry. Thromb Haemost (2019) 0.75
TCT-377 Safety of Ultra-Low Contrast Coronary Angiography in Patients with Advanced Chronic Kidney Disease. J Am Coll Cardiol (2016) 0.75
TCT-79 Course of early subclinical leaflet thrombosis after transcatheter aortic valve replacement with or without oral anticoagulation. J Am Coll Cardiol (2016) 0.75
TCT-352 Proportion of Ischemic Risk After PCI Mediated by High Platelet Reactivity on Clopidogrel: Analysis From the ADAPT-DES Study. J Am Coll Cardiol (2016) 0.75
TCT-289 Comparison of Various Scores for Predicting Success and Efficiency of Chronic Total Occlusion Percutaneous Coronary Intervention. J Am Coll Cardiol (2016) 0.75
TCT-16 Patient and Procedural Characteristics and In-Hospital Outcomes Associated With the Use of Retrograde Recanalization Techniques for Chronic Total Occlusion PCI: A Report from the Open CTO Registry. J Am Coll Cardiol (2016) 0.75
TCT-199 Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With STEMI Undergoing Primary PCI: The HORIZONS-AMI Trial. J Am Coll Cardiol (2016) 0.75
TCT-691 Sex-Specific Differences After Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients: An Analysis from the PARTNER 2 Randomized Trial. J Am Coll Cardiol (2016) 0.75
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry. JACC Cardiovasc Interv (2017) 0.75
TCT-181 Temporal Differences in Ischemic and Bleeding Risks after Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction. J Am Coll Cardiol (2016) 0.75
TCT-282 Risk Factors Associated with Adverse Events during Chronic Total Occlusion Percutaneous Coronary Interventions: A sub-Analysis of the OPEN-CTO Study. J Am Coll Cardiol (2016) 0.75